BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11443767)

  • 1. Pre-end-stage renal disease care in the United States: a state of disrepair.
    Obrador GT; Arora P; Kausz AT; Pereira BJ
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S44-54. PubMed ID: 11443767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing end-stage renal disease therapy for the patient with diabetes mellitus.
    Friedlander MA; Hricik DE
    Semin Nephrol; 1997 Jul; 17(4):331-45. PubMed ID: 9241718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal replacement therapy for diabetic end-stage renal disease. Experience of a Tunisian hospital centre.
    Abderrahim E; Zouaghi K; Hedri H; Ben Abdallah T; Ben Hamida F; Kaaroud H; Goucha R; Ben Abdallah N; Khiari K; El Younsi F; Ben Moussa F; Kheder A; Ben Maïz H
    Diabetes Metab; 2001 Nov; 27(5 Pt 1):584-90. PubMed ID: 11694858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of end-stage renal disease care in planned dialysis start and type of renal replacement therapy--a Spanish multicentre experience.
    Marrón B; Ortiz A; de Sequera P; Martín-Reyes G; de Arriba G; Lamas JM; Martínez Ocaña JC; Arrieta J; Martínez F;
    Nephrol Dial Transplant; 2006 Jul; 21 Suppl 2():ii51-5. PubMed ID: 16825262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status of end-stage renal disease care in South Asia.
    Jha V
    Ethn Dis; 2009; 19(1 Suppl 1):S1-27-32. PubMed ID: 19484871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of a pre-dialysis education programme (PDEP) on the mode of renal replacement therapy.
    Goovaerts T; Jadoul M; Goffin E
    Nephrol Dial Transplant; 2005 Sep; 20(9):1842-7. PubMed ID: 15919693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. End-stage renal disease treatment: a European perspective.
    Van Biesen W; Wiedemann M; Lameire N
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S55-62. PubMed ID: 11443769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of critically ill patients with acute kidney injury and end-stage renal disease requiring renal replacement therapy: a case-control study.
    Rocha E; Soares M; Valente C; Nogueira L; Bonomo H; Godinho M; Ismael M; Valença RV; Machado JE; Maccariello E
    Nephrol Dial Transplant; 2009 Jun; 24(6):1925-30. PubMed ID: 19164319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute renal failure in critically ill surgical patients: persistent lethality despite new modes of renal replacement therapy.
    Eachempati SR; Wang JC; Hydo LJ; Shou J; Barie PS
    J Trauma; 2007 Nov; 63(5):987-93. PubMed ID: 17993940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why do we need outcomes research in end stage renal disease?
    Nicolucci A; Procaccini DA
    J Nephrol; 2000; 13(6):401-4. PubMed ID: 11132755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Predictors of early death during dialysis].
    Caravaca F; Arrobas M; Pizarro JL; Cancho B; Cubero JJ; Espárrago JF; García MC; Sánchez-Casado E
    Nefrologia; 2001; 21(3):274-82. PubMed ID: 11471308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Options for renal replacement therapy: special considerations.
    Becker BN; Stone WJ
    Semin Nephrol; 1997 May; 17(3):176-87. PubMed ID: 9165647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Guidelines for dialysis. Replacement therapy for acute renal failure in critically ill patients].
    Fuiano G; Di Filippo S; Memoli B; Cioffi M; Caglioti A; Mazza G;
    G Ital Nefrol; 2004; 21 Suppl 28():S1-10. PubMed ID: 15724231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. End-stage renal failure and national resources: the Brazilian experience.
    Zatz R; Romão JE
    Ren Fail; 2006; 28(8):627-9. PubMed ID: 17162419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dialysis prescription and kinetics in acute renal failure.
    Clark WR; Mueller BA; Kraus MA; Macias WL
    Adv Ren Replace Ther; 1997 Apr; 4(2 Suppl 1):64-71. PubMed ID: 9113242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience: how much earlier should patients really start renal replacement therapy?
    Burkart JM
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S118-23. PubMed ID: 11443758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. End-stage renal disease in the United States: an update from the United States Renal Data System.
    Foley RN; Collins AJ
    J Am Soc Nephrol; 2007 Oct; 18(10):2644-8. PubMed ID: 17656472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duration of end-stage renal disease and kidney transplant outcome.
    Goldfarb-Rumyantzev A; Hurdle JF; Scandling J; Wang Z; Baird B; Barenbaum L; Cheung AK
    Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timing of renal replacement therapy and clinical outcomes in critically ill patients with severe acute kidney injury.
    Bagshaw SM; Uchino S; Bellomo R; Morimatsu H; Morgera S; Schetz M; Tan I; Bouman C; Macedo E; Gibney N; Tolwani A; Oudemans-van Straaten HM; Ronco C; Kellum JA;
    J Crit Care; 2009 Mar; 24(1):129-40. PubMed ID: 19272549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The epidemiology and control of anaemia among pre-ESRD patients with chronic kidney disease.
    McClellan WM; Jurkovitz C; Abramson J
    Eur J Clin Invest; 2005 Dec; 35 Suppl 3():58-65. PubMed ID: 16281960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.